Crohn's Disease Treatment Market

Global Market Study on Crohn's Disease: Anti-inflammatory Drugs Segment Anticipated to be the Most Lucrative Segment Through 2024

Crohn's Disease Market Segmented By Anti-inflammatory drugs, Immune system suppressors, Antibiotics, Biologics, Anti-diarrheal, Pain relievers DRug Type in Hospital, Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores

Industry: Healthcare

Published Date: January-2017

Format: PPT*, PDF, EXCEL

Delivery Timelines: Contact Sales

Number of Pages: 120

Report ID: PMRREP9665

Report Price

$4900*

Buy Now

Table of Content

1. Executive Summary

2. Crohn's Disease Market Overview

    2.1. Introduction

        2.1.1. Market Definition

        2.1.2. Market Taxonomy

    2.2. Crohn's Disease Market Dynamics

        2.2.1. Drivers

        2.2.2. Restraints

        2.2.3. Opportunity

        2.2.4. Value Chain

    2.3. Epidemiology

    2.4. Inflammatory Bowel Disease (IBD) Stepwise Treatment Paradigm

    2.5. Medications for Crohn’s Disease- Current & Future Therapies

3. Global Crohn's Disease Market Forecast, 2016-2024

    3.1. Introduction

        3.1.1. Y-o-Y Growth Projections

        3.1.2. Absolute $ Opportunity

    3.2. Crohn's Disease Market Trends

4. Global Crohn's Disease Market Analysis, By Drug Type

    4.1. Introduction

        4.1.1. Basis Point Share (BPS) Analysis By Drug Type

        4.1.2. Y-o-Y Growth Projections By Drug Type

    4.2. Market Size (US$ Mn) Forecast & Absolute $ Opportunity By Drug Type

        4.2.1. Anti-inflammatory drugs

        4.2.2. Immune system suppressors

        4.2.3. Antibiotics

        4.2.4. Biologics

        4.2.5. Anti-diarrheal

        4.2.6. Pain relievers

    4.3. Attractiveness Analysis By Drug Type

5. Global Crohn's Disease Market Analysis, By Distribution Channel

    5.1. Introduction

        5.1.1. Basis Point Share (BPS) Analysis By Distribution Channel

        5.1.2. Y-o-Y Growth Projections By Distribution Channel

    5.2. Market Size (US$ Mn) Forecast & Absolute $ Opportunity By Distribution Channel

        5.2.1. Hospitals

        5.2.2. Retail Pharmacies

        5.2.3. Online Pharmacies

        5.2.4. Drug Stores

    5.3. Market Attractiveness Analysis, By Distribution Channel

6. Global Crohn's Disease Market Analysis, By Region

    6.1. Introduction

        6.1.1. Basis Point Share (BPS) Analysis By Region

        6.1.2. Y-o-Y Growth Projections By Region

    6.2. Market Size (US$ Mn) Forecast & Absolute $ Opportunity By Region

        6.2.1. North America

        6.2.2. Europe

        6.2.3. Asia Pacific

        6.2.4. Latin America

        6.2.5. Middle East and Africa (MEA)

    6.3. Market Attractiveness Analysis By Region

7. North America Crohn's Disease Market Analysis and Forecast

    7.1. Introduction

        7.1.1. Basis Point Share (BPS) Analysis By Country

        7.1.2. Y-o-Y Growth Projections By Country

        7.1.3. Market Attractiveness Analysis By Country

    7.2. Market Size (US$ Mn) Forecast By Country

        7.2.1. U.S.

        7.2.2. Canada

    7.3. Market Size (US$ Mn) Forecast By Drug type

        7.3.1. Anti-inflammatory drugs

        7.3.2. Immune system suppressors

        7.3.3. Antibiotics

        7.3.4. Biologics

        7.3.5. Anti-diarrheal

        7.3.6. Pain relievers

    7.4. Market Size (US$ Mn) Forecast By Distribution Channel

        7.4.1. Hospitals

        7.4.2. Retail Pharmacies

        7.4.3. Online Pharmacies

        7.4.4. Drug Stores

    7.5. Market Attractiveness Analysis

        7.5.1. By Country

        7.5.2. By Drug Type

        7.5.3. By Distribution Channel

8. Latin America Crohn’s Disease Market Analysis and Forecast

    8.1. Introduction

        8.1.1. Basis Point Share (BPS) Analysis By Country

        8.1.2. Y-o-Y Growth Projections By Country

        8.1.3. Market Attractiveness Analysis By Country

    8.2. Market Size (US$ Mn) Forecast By Country

        8.2.1. Brazil

        8.2.2. Mexico

        8.2.3. Latin America

    8.3. Market Size (US$ Mn) Forecast By Drug type

        8.3.1. Anti-inflammatory drugs

        8.3.2. Immune system suppressors

        8.3.3. Antibiotics

        8.3.4. Biologics

        8.3.5. Anti-diarrheal

        8.3.6. Pain relievers

    8.4. Market Size (US$ Mn) Forecast By Distribution Channel

        8.4.1. Hospitals

        8.4.2. Retail Pharmacies

        8.4.3. Online Pharmacies

        8.4.4. Drug Stores

    8.5. Market Attractiveness Analysis

        8.5.1. By Country

        8.5.2. By Drug Type

        8.5.3. By Distribution Channel

9. Europe Crohn’s Disease Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Basis Point Share (BPS) Analysis By Country

        9.1.2. Y-o-Y Growth Projections By Country

        9.1.3. Market Attractiveness Analysis By Country

    9.2. Market Size (US$ Mn) Forecast By Country

        9.2.1. Germany

        9.2.2. U.K.

        9.2.3. France

        9.2.4. Italy

        9.2.5. Spain

        9.2.6. Russia

        9.2.7. Rest of Europe

    9.3. Market Size (US$ Mn) Forecast By Drug type

        9.3.1. Anti-inflammatory drugs

        9.3.2. Immune system suppressors

        9.3.3. Antibiotics

        9.3.4. Biologics

        9.3.5. Anti-diarrheal

        9.3.6. Pain relievers

    9.4. Market Size (US$ Mn) Forecast By Distribution Channel

        9.4.1. Hospitals

        9.4.2. Retail Pharmacies

        9.4.3. Online Pharmacies

        9.4.4. Drug Stores

    9.5. Market Attractiveness Analysis

        9.5.1. By Country

        9.5.2. By Drug Type

        9.5.3. By Distribution Channel

10. Asia Pacific Crohn’s Disease Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Basis Point Share (BPS) Analysis By Country

        10.1.2. Y-o-Y Growth Projections By Country

        10.1.3. Market Attractiveness Analysis By Country

    10.2. Market Size (US$ Mn) Forecast By Country

        10.2.1. China

        10.2.2. Japan

        10.2.3. India

        10.2.4. Australia and New Zealand

        10.2.5. ASEAN

        10.2.6. Rest of Asia-Pacific

    10.3. Market Size (US$ Mn) Forecast By Drug type

        10.3.1. Anti-inflammatory drugs

        10.3.2. Immune system suppressors

        10.3.3. Antibiotics

        10.3.4. Biologics

        10.3.5. Anti-diarrheal

        10.3.6. Pain relievers

    10.4. Market Size (US$ Mn) Forecast By Distribution Channel

        10.4.1. Hospitals

        10.4.2. Retail Pharmacies

        10.4.3. Online Pharmacies

        10.4.4. Drug Stores

    10.5. Market Attractiveness Analysis

        10.5.1. By Country

        10.5.2. By Drug Type

        10.5.3. By Distribution Channel

11. Middle East and Africa (MEA) Crohn’s Disease Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Basis Point Share (BPS) Analysis By Country

        11.1.2. Y-o-Y Growth Projections By Country

        11.1.3. Market Attractiveness Analysis By Country

    11.2. Market Size (US$ Mn) Forecast By Country

        11.2.1. GCC Countries

        11.2.2. South Africa

        11.2.3. Rest of MEA

    11.3. Market Size (US$ Mn) Forecast By Drug type

        11.3.1. Anti-inflammatory drugs

        11.3.2. Immune system suppressors

        11.3.3. Antibiotics

        11.3.4. Biologics

        11.3.5. Anti-diarrheal

        11.3.6. Pain relievers

    11.4. Market Size (US$ Mn) Forecast By Distribution Channel

        11.4.1. Hospitals

        11.4.2. Retail Pharmacies

        11.4.3. Online Pharmacies

        11.4.4. Drug Stores

    11.5. Market Attractiveness Analysis

        11.5.1. By Country

        11.5.2. By Drug Type

        11.5.3. By Distribution Channel

12. Competition Landscape

    12.1. Competition Dashboard

    12.2. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)

    12.3. Global Players

        12.3.1. Allergan, Inc.,

        12.3.2. UCB S.A.

        12.3.3. AbbVie Inc.

        12.3.4. Perrigo Company plc

        12.3.5. Takeda Pharmaceutical Company Limited

        12.3.6. Pfizer Inc.

        12.3.7. Johnson & Johnson Services, Inc.

        12.3.8. Bayer AG

        12.3.9. Ferring B.V.

13. Assumptions and Acronyms Used

14. Research Methodology

Sample Report

Report Sample is Available

In-depth report coverage is now just a few seconds away

Download PDF Get FREE Report Sample

List Of Table

Table 01: Global Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Drug Type, 2015-2024

Table 02: Global Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015-2024

Table 03: Global Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Region, 2015-2024

Table 04: North America Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Country, 2015-2024

Table 05: North America Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Drug Type, 2015-2024

Table 06: North America Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015-2024

Table 07: Latin America Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Country, 2015-2024

Table 08: Latin America Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Drug Type, 2015-2024

Table 09: Latin America Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015-2024

Table 10: Europe Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Country, 2015-2024

Table 11: Europe Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Drug Type, 2015-2024

Table 12: Europe Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015-2024

Table 13: APAC Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Country, 2015-2024

Table 14: APAC Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Drug Type, 2015-2024

Table 15: APAC Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015-2024

Table 16: MEA Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Country, 2015-2024

Table 17: MEA Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Drug Type, 2015-2024

Table 18: MEA Crohn's Disease Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015-2024

Custom Report Cover

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

> Get a Customized Version

- List Of Chart -

Figure 01: Global Crohn's Disease Market Value Share By, Region, 2015 A

Figure 02: Global Crohn's Disease Market Value Share By, Drug Type, 2015 A

Figure 03: Global Crohn's Disease Market Value Share By, Distribution Channel, 2015 A

Figure 04: Global Crohn's Disease Market Value (US$ Mn) & Y-o-Y Growth (%), 2015-2024

Figure 05: Global Crohn's Disease Market Absolute $ Opportunity, 2016-2024

Figure 06: Global Crohn's Disease Market Share and BPS Analysis (%) By Drug Type, 2016 & 2024

Figure 07: Global Crohn's Disease Y-o-Y growth (%) By Drug Type, 2016-2024

Figure 08: Global Crohn's Disease Market Absolute $ Opportunity By Anti-inflammatory Drugs Segment,

Figure 09: Global Crohn's Disease Market Absolute $ Opportunity By Immune System Suppressors Segment, 2016-2024

Figure 10: Global Crohn's Disease Market Absolute $ Opportunity By Antibiotics Segment, 2016-2024

Figure 11: Global Crohn's Disease Market Absolute $ Opportunity By Biologics Segment, 2016-2024

Figure 12: Global Crohn's Disease Market Absolute $ Opportunity By Anti-diarrheal Segment, 2016-2024

Figure 13: Global Crohn's Disease Market Absolute $ Opportunity By Pain Relievers Segment, 2016-2024

Figure 14: Global Crohn's Disease Market Attractiveness Analysis By Drug Type, 2016-2024

Figure 15: Global Crohn's Disease Market Share and BPS Analysis (%) By Distribution Channel, 2016 & 2024

Figure 16: Global Crohn's Disease Y-o-Y growth (%) By Distribution Channel, 2016-2024

Figure 17: Global Crohn's Disease Market Absolute $ Opportunity By Hospital Pharmacies Segment,

Figure 18: Global Crohn's Disease Market Absolute $ Opportunity By Retail Pharmacies Segment, 2016-2024

Figure 19: Global Crohn's Disease Market Absolute $ Opportunity By Online Pharmacies Segment, 2016-2024

Figure 20: Global Crohn's Disease Market Absolute $ Opportunity By Drug Stores Segment, 2016-2024

Figure 21: Global Crohn's Disease Market Attractiveness Analysis By Distribution Channel, 2016-2024

Figure 22: Global Crohn's Disease Market Value (US$ Mn) and CAGR (%) By Region, 2015, 2020, and 2024

Figure 23: Global Crohn's Disease Market Share and BPS Analysis (%) By Region, 2016 & 2024

Figure 24: Global Crohn's Disease Y-o-Y growth (%) By Region, 2016-2024

Figure 25: North America Crohn's Disease Market Absolute $ Opportunity, 2016-2024

Figure 26: Latin America Crohn's Disease Market Absolute $ Opportunity, 2016-2024

Figure 27: Europe Crohn's Disease Market Absolute $ Opportunity, 2016-2024

Figure 28: APAC Crohn's Disease Market Absolute $ Opportunity, 2016-2024

Figure 29: Middle East and Africa Crohn's Disease Market Absolute $ Opportunity, 2016-2024

Figure 30: Global Crohn's Disease Market Attractiveness Analysis By Region, 2016-2024

Figure 31: North America Crohn's Disease Market Share Analysis (%) By Country, 2016 & 2024

Figure 32: North America Crohn's Disease Market Attractiveness Analysis By Country, 2016-2024

Figure 33: North America Crohn's Disease Y-o-Y growth (%) By Country, 2016-2024

Figure 34: North America Crohn's Disease Market Attractiveness Analysis By Drug Type, 2016-2024

Figure 35: North America Crohn's Disease Market Attractiveness Analysis By Distribution Channel, 2016-2024

Figure 36: Latin America Crohn's Disease Market Share Analysis (%) By Country, 2016 & 2024

Figure 37: Latin America Crohn's Disease Market Attractiveness Analysis By Country, 2016-2024

Figure 38: Latin America Crohn's Disease Y-o-Y growth (%) By Country, 2016-2024

Figure 39: Latin America Crohn's Disease Market Attractiveness Analysis By Drug Type, 2016-2024

Figure 40: Latin America Crohn's Disease Market Attractiveness Analysis By Distribution Channel, 2016-2024

Figure 41: Europe Crohn's Disease Market Share Analysis (%) By Country, 2016 & 2024

Figure 42: Europe Crohn's Disease Market Attractiveness Analysis By Country, 2016-2024

Figure 43: Europe Crohn's Disease Y-o-Y growth (%) By Country, 2016-2024

Figure 44: Europe Crohn's Disease Market Attractiveness Analysis By Drug Type, 2016-2024

Figure 45: Europe Crohn's Disease Market Attractiveness Analysis By Distribution Channel, 2016-2024

Figure 46: APAC Crohn's Disease Market Share Analysis (%) By Country, 2016 & 2024

Figure 47: APAC Crohn's Disease Market Attractiveness Analysis By Country, 2016-2024

Figure 48: APAC Crohn's Disease Y-o-Y growth (%) By Country, 2016-2024

Figure 49: APAC Crohn's Disease Market Attractiveness Analysis By Drug Type, 2016-2024

Figure 50: APAC Crohn's Disease Market Attractiveness Analysis By Distribution Channel, 2016-2024

Figure 51: MEA Crohn's Disease Market Share Analysis (%) By Country, 2016 & 2024

Figure 52: MEA Crohn's Disease Market Attractiveness Analysis By Country, 2016-2024

Figure 53: MEA Crohn's Disease Y-o-Y growth (%) By Country, 2016-2024

Figure 54: MEA Crohn's Disease Market Attractiveness Analysis By Drug Type, 2016-2024

Figure 55: MEA Crohn's Disease Market Attractiveness Analysis By Distribution Channel, 2016-2024

Thank you for taking time to visit our website, click like if you found the information on this page useful?

This site uses cookies, including third-party cookies, that help us to provide and improve our services.
Google translate